129 related articles for article (PubMed ID: 2541903)
1. Intravenous yohimbine. Selective enhancer of norepinephrine and cortisol secretion and systolic blood pressure in humans.
Grunhaus L; Tiongco D; Zelnik T; Flegel P; Hollingsworth PJ; Smith CB
Clin Neuropharmacol; 1989 Apr; 12(2):106-14. PubMed ID: 2541903
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam.
Fries E; Hellhammer DH; Hellhammer J
Psychoneuroendocrinology; 2006 Nov; 31(10):1278-88. PubMed ID: 17097811
[TBL] [Abstract][Full Text] [Related]
3. alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity.
Pasquali R; Vicennati V; Calzoni F; Gnudi U; Gambineri A; Ceroni L; Cortelli P; Menozzi R; Sinisi R; Rio GD
Clin Endocrinol (Oxf); 2000 Apr; 52(4):413-21. PubMed ID: 10762283
[TBL] [Abstract][Full Text] [Related]
4. Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans.
Goldberg MR; Hollister AS; Robertson D
Hypertension; 1983; 5(5):772-8. PubMed ID: 6352483
[TBL] [Abstract][Full Text] [Related]
5. Alpha 2-adrenergic receptor function in depression. The cortisol response to yohimbine.
Price LH; Charney DS; Rubin AL; Heninger GR
Arch Gen Psychiatry; 1986 Sep; 43(9):849-58. PubMed ID: 3019271
[TBL] [Abstract][Full Text] [Related]
6. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
[TBL] [Abstract][Full Text] [Related]
7. Role of alpha-adrenergic mechanism in effects of morphine on the hypothalamo-pituitary-adrenocortical and cardiovascular systems in the rat.
Suemaru S; Dallman MF; Darlington DN; Cascio CS; Shinsako J
Neuroendocrinology; 1989 Feb; 49(2):181-90. PubMed ID: 2542829
[TBL] [Abstract][Full Text] [Related]
8. Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.
Krystal JH; McDougle CJ; Woods SW; Price LH; Heninger GR; Charney DS
Psychopharmacology (Berl); 1992; 108(3):313-9. PubMed ID: 1355923
[TBL] [Abstract][Full Text] [Related]
9. Effects of hydrocortisone and yohimbine on selective attention to emotional cues.
Metz S; Chae WR; Deuter CE; Otte C; Wingenfeld K
J Psychopharmacol; 2021 Jun; 35(6):755-759. PubMed ID: 33779376
[TBL] [Abstract][Full Text] [Related]
10. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.
McDougle CJ; Krystal JH; Price LH; Heninger GR; Charney DS
Psychopharmacology (Berl); 1995 Mar; 118(2):127-35. PubMed ID: 7617798
[TBL] [Abstract][Full Text] [Related]
11. Psychological, cardiovascular, and endocrine changes during 6 hours of continuous infusion of epinephrine or norepinephrine in healthy volunteers.
Tulen JH; Moleman P; Blankestijn PJ; Man in't Veld AJ; van Steenis HG; Boomsma F
Psychosom Med; 1993; 55(1):61-9. PubMed ID: 8446743
[TBL] [Abstract][Full Text] [Related]
12. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
Charney DS; Woods SW; Goodman WK; Heninger GR
Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
[TBL] [Abstract][Full Text] [Related]
13. Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress.
Udelsman R; Norton JA; Jelenich SE; Goldstein DS; Linehan WM; Loriaux DL; Chrousos GP
J Clin Endocrinol Metab; 1987 May; 64(5):986-94. PubMed ID: 3031124
[TBL] [Abstract][Full Text] [Related]
14. The effect of elevated systemic cortisol levels on plasma catecholamines in Cushing's syndrome patients with and without depressed mood.
Cameron OG; Starkman MN; Schteingart DE
J Psychiatr Res; 1995; 29(5):347-60. PubMed ID: 8748060
[TBL] [Abstract][Full Text] [Related]
15. alpha 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine.
Heninger GR; Charney DS; Price LH
Arch Gen Psychiatry; 1988 Aug; 45(8):718-26. PubMed ID: 2840050
[TBL] [Abstract][Full Text] [Related]
16. Effects of yohimbine on human sympathetic nervous system function.
Murburg MM; Villacres EC; Ko GN; Veith RC
J Clin Endocrinol Metab; 1991 Oct; 73(4):861-5. PubMed ID: 1890156
[TBL] [Abstract][Full Text] [Related]
17. Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.
Charney DS; Breier A; Jatlow PI; Heninger GR
Psychopharmacology (Berl); 1986; 88(2):133-40. PubMed ID: 3081923
[TBL] [Abstract][Full Text] [Related]
18. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
Torpy DJ; Papanicolaou DA; Lotsikas AJ; Wilder RL; Chrousos GP; Pillemer SR
Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933
[TBL] [Abstract][Full Text] [Related]
19. Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine.
Charney DS; Heninger GR; Sternberg DE
Life Sci; 1982 Jun; 30(23):2033-41. PubMed ID: 6287139
[TBL] [Abstract][Full Text] [Related]
20. Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men.
Mendelson JH; Sholar MB; Goletiani N; Siegel AJ; Mello NK
Neuropsychopharmacology; 2005 Sep; 30(9):1751-63. PubMed ID: 15870834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
